b-Casomorphin (1-3)
(Synonyms: H2N-Tyr-Pro-Phe-OH ) 目录号 : GP10125Milk protein casein analog, have an opioid effect
Cas No.:72122-59-9
Sample solution is provided at 25 µL, 10mM.
b-Casomorphin (1-3), (C23H27N3O5), a tri-peptide with the sequence H2N-Tyr-Pro-Phe-OH, MW= 425.48. Casomorphins are peptides derived from the digestion of milk protein casein. The distinguishing characteristic of casomorphins is that they have an opioid effect. The most important casomorphins from bovine milk are those released from the digestion of β-casein into β-casomorphins, sometimes denoted as BCM followed by a numeral indicating the number of amino acids in the sequence. Each variant fits into one of two main categories known as A1 and A2. In cattle, A1-type β-caseins have the amino acid histidine at position 67, whereas the A2-type β-caseins have the amino acid proline at position 67. Laboratory experiments show that the casomorphin known as BCM7 is released only from the A1-type β-caseins[1]. The potential release of BCM7 is about 0.4 grams per litre of milk (assuming as above that there are 12g of β-casein per litre).Human digestion may break down casomorphins into inactive dipeptides by the enzyme dipeptidyl peptidase-4[2]. This enzyme is found in the digestive tract and in some endocrine cells. Casein has been documented to break down in the stomach to produce the peptide casomorphin (above stated that "Human digestion may break down casomorphins into inactive dipeptides by the enzyme dipeptidyl peptidase-4"), an opioid that acts as a histamine releaser[3].
References:
1. Jinsmaa Y, Yoshikawa M, 1999; "Enzymatic release of neocasomorphin and beta-casomorphinfrom bovine beta-casein"; Peptides 20:957-962
2. Converse PJ, Hamosh A, McKusickVA(2005). DIPEPTIDYL PEPTIDASE IV; DPP4. Online Mendelian Inheritance inMan.
3. Kurek M, Przybilla B, Hermann K, Ring J (1992). "A naturally occurring opioid peptide from cow's milk, beta-casomorphine-7, is a direct histamine releaser in man". Int Arch Allergy Immunol 97 (2): 115–120.g.
Cas No. | 72122-59-9 | SDF | |
别名 | H2N-Tyr-Pro-Phe-OH | ||
化学名 | 2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid | ||
Canonical SMILES | C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)O | ||
分子式 | C23H27N3O5 | 分子量 | 425.48 |
溶解度 | ≥ 42.5mg/mL in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.3503 mL | 11.7514 mL | 23.5029 mL |
5 mM | 0.4701 mL | 2.3503 mL | 4.7006 mL |
10 mM | 0.235 mL | 1.1751 mL | 2.3503 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet